Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/24/23 06:15 | 2/23/23 | VYGR | Health | BioPrd | Biological Products, (No Diag | Neurocrine Biosciences Inc | CA | T | P | 39,033 | 8.88 | 0 | 4,396 | 105 | 8,575 | D | |||||||||||||||
6/23/22 17:21 | 6/21/22 | VYGR | Health | BioPrd | Biological Products, (No Diag | Ecor1 Capital, LLC | CA | T | P.m | 2,662 | 5.58 | 0 | 477 | 11 | 4,754 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |